Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0001415889-24-007570 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | 2024-03-07 | KYNB | Wettig Thane | CEO | P - Purchase | $1.91 | +50.0K | 470.2K | +12% | +$95.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | P | A | 50,000 | $1.91 | 470,178 | D | — | — |